EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Does faster aspart improve time in range in children with type 1 diabetes with glycaemia close to target on insulin pump therapy?

Kowalczyk-Korcz Emilia iD, Dymińska Magdalena iD, Groele Lidia iD, Szypowska Agnieszka iD

Diabetic Medicine · 2026

DOI: 10.1111/dme.70330 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetic Medicine, 2026. Verfasst von Kowalczyk-Korcz Emilia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Diabetology and Pediatrics, The Children's Clinical Hospital Named After J.P. Brudziński, University Clinical Center of the W…. Hauptthemen laut MEDLINE: Blood Glucose, Diabetes Mellitus, Type 1, Hypoglycemic Agents, Insulin Aspart. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Dexcom, Warszawski Uniwersytet Medyczny.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To evaluate whether faster insulin aspart (FIA) improves time in range (TIR) compared with standard insulin aspart (SIA) in children and adolescents with type 1 diabetes achieving glycaemia close to target treated with continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM).

Methods

This prospective, open‐label, randomized, 1:1 crossover trial included participants aged 6–17 years with T1D duration of ≥1 year, CSII use ≥3 months, CGM use ≥1 month, and HbA1c 64 mmol/mol (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood GlucoseDiabetes Mellitus, Type 1Hypoglycemic AgentsInsulin AspartInsulin Infusion SystemsAdolescentChildFemaleHumansMaleContinuous Glucose MonitoringCross-Over StudiesGlycated HemoglobinProspective Studies

Stichwörter der Autor:innen

Glycaemic controlGlycaemic variabilitycontinuous blood glucose monitoringinsulin Aspartrapid‐acting insulintreatment outcometype 1 diabetes mellitus

Substanzen

Blood GlucoseGlycated HemoglobinHypoglycemic AgentsInsulin Aspart

Autor:innen und Institutionen

  • Department of Pediatric Diabetology and Pediatrics, The Children's Clinical Hospital Named After J.P. Brudziński, University Clinical Center of the Warsaw Medical University, Warsaw, Poland.
  • Department of Diabetology and Pediatrics, Medical University of Warsaw, Warsaw, Poland.

ORCID-Profile: Kowalczyk-Korcz Emilia, Dymińska Magdalena, Groele Lidia, Szypowska Agnieszka

Förderung

  • Dexcom
  • Warszawski Uniwersytet Medyczny

Zitieren

APA

Emilia, K. K., Magdalena, D., Lidia, G., & Agnieszka, S. (2026). Does faster aspart improve time in range in children with type 1 diabetes with glycaemia close to target on insulin pump therapy?. Diabetic Medicine. https://doi.org/10.1111/dme.70330

Vancouver

Emilia KK, Magdalena D, Lidia G, Agnieszka S. Does faster aspart improve time in range in children with type 1 diabetes with glycaemia close to target on insulin pump therapy?. Diabetic Medicine. 2026. doi:10.1111/dme.70330

BibTeX
@article{Emilia2026,
  author = {Emilia, Kowalczyk-Korcz and Magdalena, Dymińska and Lidia, Groele and Agnieszka, Szypowska},
  title = {Does faster aspart improve time in range in children with type 1 diabetes with glycaemia close to target on insulin pump therapy?},
  journal = {Diabetic Medicine},
  year = {2026},
  doi = {10.1111/dme.70330}
}
Kostenlos starten →